
Younger and less heavy smokers are more likely to recommend e-cigarettes to older heavy smokers who have tried but failed to quit smoking in the past, according to a recent study titled "Many doctors have misconceptions about e-cigarettes". The study found that due to these misconceptions, many doctors do not recommend e-cigarettes.
A study conducted between 2018 and 2019 surveyed 2,058 American doctors. Unfortunately, 60% of the doctors mistakenly believed that electronic cigarette products were as harmful as combustible tobacco products. However, the researchers found that doctors who believed in harm reduction, had experience with smoking cessation, and were asked about e-cigarettes by their patients were more likely to recommend these products.
.com Translation: Image source: vapingpost.com
According to Dr. Cristine Delnevo, a chief researcher quoted by Filter, patient inquiries about e-cigarettes may be linked to an increase in the recommendation of e-cigarettes. This relationship has been noticed before in the context of general smoking cessation. Interestingly, recent data collection efforts have also highlighted that patients are asking about nicotine pouches, and doctors are learning about these products from their patients.
The data indicates that education for doctors is crucial.
Another noteworthy finding is that doctors are more likely to recommend e-cigarettes to older heavy smokers who have attempted to quit smoking but failed, and they are more willing to prescribe recognized NRT for younger and lighter smokers who are trying to quit smoking for the first time.
Delenevo emphasized the importance of educating healthcare professionals about e-cigarettes, citing the findings of a recent study. "These research results indicate that addressing doctors' misconceptions and educating them on the efficacy of e-cigarettes is crucial, particularly in correcting their erroneous belief that all tobacco products are equally harmful, instead of recognizing that burning tobacco is the most dangerous fact to date.
Statement:
This article is compiled from third-party information and is intended for industry professionals for educational and informational purposes.
This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is solely intended for communication and research within the industry.
Due to limitations in our translation abilities, the translated article may not fully capture the exact meaning of the original. Please refer to the original text for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.
The compilation of this information is the property of the original media and author. If there is any infringement, please contact us to delete it.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.









